Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin

Autor: Dafydd G. Thomas, Iberê C. Soares, Joanne H. Heaton, Gary D. Hammer, Derek P. Simon, Alex C. Kim, Antonio M. Lerario, Maria Candida Barisson Villares Fragoso, Ana Claudia Latronico, Lorena de Oliveira Lima, Thomas J. Giordano, Michelle A. Wood, Madson Q. Almeida, Rork Kuick, Ferdous M. Barlaskar, Elisabeth Starnes
Rok vydání: 2012
Předmět:
medicine.medical_specialty
Adenoma
endocrine system diseases
Lymphoid Enhancer-Binding Factor 1
Adenomatous Polyposis Coli Protein
Biology
medicine.disease_cause
Adrenocortical adenoma
Pathology and Forensic Medicine
Genomic Imprinting
Mice
Adrenal Cortex Hormones
Insulin-Like Growth Factor II
Internal medicine
medicine
Biomarkers
Tumor

Adrenocortical carcinoma
Animals
Humans
beta Catenin
Neoplasm Staging
Proportional Hazards Models
Mice
Knockout

Hyperplasia
Protein Stability
Wnt signaling pathway
Regular Article
DNA Methylation
medicine.disease
Prognosis
Adrenal Cortex Neoplasms
Up-Regulation
Gene Expression Regulation
Neoplastic

Protein Transport
stomatognathic diseases
Endocrinology
Cell Transformation
Neoplastic

Catenin
Insulin-like growth factor 2
Multivariate Analysis
Mutation
Cancer research
biology.protein
Disease Progression
Neoplasm Grading
Carcinogenesis
Zdroj: The American Journal of Pathology. 181(3):1017-1033
ISSN: 0002-9440
DOI: 10.1016/j.ajpath.2012.05.026
Popis: Dysregulation of the WNT and insulin-like growth factor 2 (IGF2) signaling pathways has been implicated in sporadic and syndromic forms of adrenocortical carcinoma (ACC). Abnormal β-catenin staining and CTNNB1 mutations are reported to be common in both adrenocortical adenoma and ACC, whereas elevated IGF2 expression is associated primarily with ACC. To better understand the contribution of these pathways in the tumorigenesis of ACC, we examined clinicopathological and molecular data and used mouse models. Evaluation of adrenal tumors from 118 adult patients demonstrated an increase in CTNNB1 mutations and abnormal β-catenin accumulation in both adrenocortical adenoma and ACC. In ACC, these features were adversely associated with survival. Mice with stabilized β-catenin exhibited a temporal progression of increased adrenocortical hyperplasia, with subsequent microscopic and macroscopic adenoma formation. Elevated Igf2 expression alone did not cause hyperplasia. With the combination of stabilized β-catenin and elevated Igf2 expression, adrenal glands were larger, displayed earlier onset of hyperplasia, and developed more frequent macroscopic adenomas (as well as one carcinoma). Our results are consistent with a model in which dysregulation of one pathway may result in adrenal hyperplasia, but accumulation of a second or multiple alterations is necessary for tumorigenesis.
Databáze: OpenAIRE